BackCan-Fite Biopharma Overview
Can-Fite Biopharma Ltd - ADR

Can-Fite Biopharma Target Price

Where could CANF trade next? Consensus target price: $8.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.17

Average Target Price

$8.00268.7% upside

1 analysts in the last 4 months

High: $8 | Low: $8

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-02H.C. Wainwright$8268.7% upsideOpen
2026-05-12H.C. WainwrightSwayampakula Ramakanth$5130.4% upsideOpen
2025-04-15Industrial Alliance SecuritiesJames Molloy$904047.5% upsideOpen
2024-07-17EF HuttonJason Kolbert$2009116.6% upsideOpen

Can-Fite Biopharma (CANF) FAQ

The latest target price for CANF is $8. Investors often review this figure alongside Can-Fite Biopharma's historical trend and sector peers before judging valuation or financial health.

Can-Fite Biopharma trades near $2.17 while the consensus target sits at $8 (268.7% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting CANF's target price ($8), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Can-Fite Biopharma's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.